1. Jin D.C., Han J.S.. Renal replacement therapy in Korea, 2012.
Kidney Res Clin Pract 33:2014;9–18.
2. U.S. Renal Data System (2013) . Annual Data Report: Atlas of Chronic Kidney Disease and End-Stage Renal Disease in the United States. 2013. Available at:
https://www.usrds.org/atlas13.aspx [Date accessed: 02 August 2015].
3. Kim H., Kim K.H., Park K., Kang S.W., Yoo T.H., Ahn S.V., Ahn H.S., Hann H.J., Lee S., Ryu J.H., Kim S.J., Kang D.H., Choi K.B., Ryu D.R.. A population-based approach indicates an overall higher patient mortality with peritoneal dialysis compared to hemodialysis in Korea.
Kidney Int 86:2014;991–1000.
4. Choi H., Kim M., Kim H., Lee J.P., Lee J., Park J.T., Kim K.H., Ahn H.S., Hann H.J., Ryu D.R.. Excess mortality among patients on dialysis: comparison with the general population in Korea.
Kidney Res Clin Pract 33:2014;89–94.
5. Shih Y.C., Guo A., Just P.M., Mujais S.. Impact of initial dialysis modality and modality switches on Medicare expenditures of end-stage renal disease patients.
Kidney Int 68:2005;319–329.
6. Pajek J., Hutchison A.J., Bhutani S., Brenchley P.E., Hurst H., Perme M.P., Summers A.M., Vardhan A.. Outcomes of peritoneal dialysis patients and switching to hemodialysis: a competing risks analysis.
Perit Dial Int 34:2014;289–298.
7. Bechade C., Guittet L., Evans D., Verger C., Ryckelynck J.P., Lobbedez T.. Early failure in patients starting peritoneal dialysis: a competing risks approach.
Nephrol Dial Transplant 29:2014;2127–2135.
8. Wong J.S., Port F.K., Hulbert-Shearon T.E., Carroll C.E., Wolfe R.A., Agodoa L.Y., Daugirdas J.T.. Survival advantage in Asian American end-stage renal disease patients.
Kidney Int 55:1999;2515–2523.
9. Teixeira L., Rodrigues A., Carvalho M.J., Cabrita A., Mendonca D.. Modelling competing risks in nephrology research: an example in peritoneal dialysis.
BMC Nephrol 14:2013;110.
10. Beuscart J.B., Pagniez D., Boulanger E., Lessore de Sainte Foy C., Salleron J., Frimat L., Duhamel A.. Overestimation of the probability of death on peritoneal dialysis by the Kaplan-Meier method: advantages of a competing risks approach.
BMC Nephrol 13:2012;31.
11. Charlson M.E., Pompei P., Ales K.L., MacKenzie C.R.. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation.
J Chronic Dis 40:1987;373–383.
12. Quan H., Sundararajan V., Halfon P., Fong A., Burnand B., Luthi J.C., Saunders L.D., Beck C.A., Feasby T.E., Ghali W.A.. Coding algorithms for defining comorbidities in ICD-9-CM and ICD-10 administrative data.
Med Care 43:2005;1130–1139.
13. Fine J.P., Gray R.J.. A proportional hazards model for the subdistribution of a competing risk.
J Am Stat Assoc 94:1999;496–509.
14. Wanner C., Tonelli M.; Kidney Disease: Improving Global Outcomes Lipid Guideline Development Work Group Members. KDIGO Clinical Practice Guideline for Lipid Management in CKD: summary of recommendation statements and clinical approach to the patient.
Kidney Int 85:2014;1303–1309.
15. Jager K.J., Merkus M.P., Dekker F.W., Boeschoten E.W., Tijssen J.G., Stevens P., Bos W.J., Krediet R.T.. Mortality and technique failure in patients starting chronic peritoneal dialysis: results of The Netherlands Cooperative Study on the Adequacy of Dialysis. NECOSAD Study Group.
Kidney Int 55:1999;1476–1485.
16. Kumar V.A., Sidell M.A., Yang W.T., Jones J.P.. Predictors of peritonitis, hospital days, and technique survival for peritoneal dialysis patients in a managed care setting.
Perit Dial Int 34:2014;171–178.
17. Maiorca R., Vonesh E., Cancarini G.C., Cantaluppi A., Manili L., Brunori G., Camerini C., Feller P., Strada A.. A six-year comparison of patient and technique survivals in CAPD and HD.
Kidney Int 34:1988;518–524.
18. Han S.H., Lee J.E., Kim D.K., Moon S.J., Kim H.W., Chang J.H., Kim B.S., Kang S.W., Choi K.H., Lee H.Y., Han D.S.. Long-term clinical outcomes of peritoneal dialysis patients: single center experience from Korea.
Perit Dial Int 28(Suppl 3):2008;S21–S26.
19. Schaubel D.E., Blake P.G., Fenton S.S.. Effect of renal center characteristics on mortality and technique failure on peritoneal dialysis.
Kidney Int 60:2001;1517–1524.
20. Chidambaram M., Bargman J.M., Quinn R.R., Austin P.C., Hux J.E., Laupacis A.. Patient and physician predictors of peritoneal dialysis technique failure: a population based, retrospective cohort study.
Perit Dial Int 31:2011;565–573.
21. Kim D.K., Yoo T.H., Ryu D.R., Xu Z.G., Kim H.J., Choi K.H., Lee H.Y., Han D.S., Kang S.W.. Changes in causative organisms and their antimicrobial susceptibilities in CAPD peritonitis: a single center's experience over one decade.
Perit Dial Int 24:2004;424–432.
22. Ryu J.H., Kim H., Kim K.H., Hann H.J., Ahn H.S., Lee S., Kim S.J., Kang D.H., Choi K.B., Ryu D.R.. Improving survival rate of Korean patients initiating dialysis.
Yonsei Med J 56:2015;666–675.
23. Lobbedez T., Verger C., Ryckelynck J.P., Fabre E., Evans D.. Is assisted peritoneal dialysis associated with technique survival when competing events are considered?
Clin J Am Soc Nephrol 7:2012;612–618.
24. Fang W., Qian J., Lin A., Rowaie F., Ni Z., Yao Q., Bargman J.M., Oreopoulos D.G.. Comparison of peritoneal dialysis practice patterns and outcomes between a Canadian and a Chinese centre.
Nephrol Dial Transplant 23:2008;4021–4028.
25. Fang W., Yang X., Kothari J., Khandelwal M., Naimark D., Jassal S.V., Bargman J., Oreopoulos D.G.. Patient and technique survival of diabetics on peritoneal dialysis: one-center's experience and review of the literature.
Clin Nephrol 69:2008;193–200.
26. Zimmerman S.W., Oxton L.L., Bidwell D., Wakeen M.. Long-term outcome of diabetic patients receiving peritoneal dialysis.
Perit Dial Int 16:1996;63–68.
27. Konner K.. Primary vascular access in diabetic patients: an audit.
Nephrol Dial Transplant 15:2000;1317–1325.
28. Cotovio P., Rocha A., Carvalho M.J., Teixeira L., Mendonça D., Cabrita A., Rodrigues A.. Better outcomes of peritoneal dialysis in diabetic patients in spite of risk of loss of autonomy for home dialysis.
Perit Dial Int 34:2014;775–780.
29. Sekercioglu N., Dimitriadis C., Pipili C., Elias R.M., Kim J., Oreopoulos D.G., Bargman J.M.. Glycemic control and survival in peritoneal dialysis patients with diabetes mellitus.
Int Urol Nephrol 44:2012;1861–1869.
30. de Andrade Bastos K., Qureshi A.R., Lopes A.A., Fernandes N., Barbosa L.M., Pecoits-Filho R., Divino-Filho J.C.; Brazilian Peritoneal Dialysis Multicenter Study (BRAZPD) Group. Family income and survival in Brazilian Peritoneal Dialysis Multicenter Study Patients (BRAZPD): time to revisit a myth?
Clin J Am Soc Nephrol 6:2011;1676–1683.
31. Marinovich S., Lavorato C., Rosa-Diez G., Bisigniano L., Fernández V., Hansen-Krogh D.. The lack of income is associated with reduced survival in chronic haemodialysis.
Nefrologia 32:2012;79–88.
32. Ward M.M.. Laboratory abnormalities at the onset of treatment of end-stage renal disease: are there racial or socioeconomic disparities in care?
Arch Intern Med 167:2007;1083–1091.
33. Fraser S.D., Roderick P.J., Casey M., Taal M.W., Yuen H.M., Nutbeam D.. Prevalence and associations of limited health literacy in chronic kidney disease: a systematic review.
Nephrol Dial Transplant 28:2013;129–137.
34. Jain D., Sheth H., Green J.A., Bender F.H., Weisbord S.D.. Health literacy in patients on maintenance peritoneal dialysis: prevalence and outcomes.
Perit Dial Int 35:2015;96–98.
35. Descoeudres B., Koller M.T., Garzoni D., Wolff T., Steiger J., Schaub S., Mayr M.. Contribution of early failure to outcome on peritoneal dialysis.
Perit Dial Int 28:2008;259–267.